Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other Non-Current Liabilities: 2022-2025

Historic Other Non-Current Liabilities for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to $29,000.

  • Centessa Pharmaceuticals' Other Non-Current Liabilities changed negligibly% to $29,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $29,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $29,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Other Non-Current Liabilities stood at $29,000, which was down 0.00% from $29,000 recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $43,000 for Q1 2022, and its period low was $29,000 during Q4 2023.
  • Over the past 3 years, Centessa Pharmaceuticals' median Other Non-Current Liabilities value was $29,000 (recorded in 2025), while the average stood at $29,000.